Garcinol downregulates notch1 signaling via modulating mir-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells

Biotechnology and Applied Biochemistry

Volumn 64, Issue 2, 2017, Pages 165-173

  Huang, Chi Cheng ^a,b,c   Lin, Chien Min ^d   Huang, Yan Jiun ^e,f   Wei, Li ^f   Ting, Lei Li ^e   Kuo, Chia Chun ^e   Hsu, Cheyu ^e   Chiou, Jeng Fong ^c,e   Wu, Alexander T H ^f   Lee, Wei Hwa ^d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Drug resistance; Garcinol; Notch1; Pancreatic cancer stem like cells; Side population cells

Indexed keywords

CELL CULTURE; CELLS; CYTOLOGY; DISEASES; DRUG THERAPY;

DRUG RESISTANCE; GARCINOL; NOTCH1; PANCREATIC CANCERS; SIDE POPULATION CELLS;

CELL SIGNALING;

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BREAST CANCER RESISTANCE PROTEIN; GARCINOL; GEMCITABINE; HERMES ANTIGEN; MICRORNA 101; MICRORNA 181; MICRORNA 200C; MICRORNA 29B; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PLANT MEDICINAL PRODUCT; PROTEIN MCL 1; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; MICRORNA; MIRN200 MICRORNA, HUMAN; TERPENE; TUMOR MARKER; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PANC-1 CELL LINE; PHENOTYPE; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STEM CELL SELF-RENEWAL; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; PANCREATIC NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD44; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TERPENES;

EID: 85011063046     PISSN: 08854513     EISSN: 14708744     Source Type: Journal    
DOI: 10.1002/bab.1446     Document Type: Article

References (41)

1. Challen, G. A. and Little, M. H. (2006) A side order of stem cells: the SP phenotype. Stem Cells 24, 3–12.
2. Sales-Pardo, I., Avendano, A., Martinez-Munoz, V., Garcia-Escarp, M., Celis, R., Whittle, P., Barquinero, J., Domingo, J. C., Marin, P., and Petriz, J. (2006) Cell. Oncol. 28, 37–53.
3. Zhan, H. X., Xu, J. W., Wu, D., Zhang, T. P., and Hu, S. Y. (2015) Cancer Lett. 357, 429–437.
4. Tanase, C. P., Neagu, A. I., Necula, L. G., Mambet, C., Enciu, A. M., Calenic, B., Cruceru, M. L., and Albulescu, R. (2014) World J. Gastroenterol. 20, 10790–10801.
5. Chan, S. H., and Wang, L. H. (2015) J. Biomed. Sci. 22, 9.
6. Garg, M. (2015) Expert Opin. Ther. Targets 19, 285–297.
7. Garofalo, M., and Croce, C. M. (2015) Adv. Drug Deliv. Rev. 81C, 53–61.
8. Rukachaisirikul, V., Naklue, W., Sukpondma, Y., and Phongpaichit, S. (2005) Chem. Pharm. Bull. 53, 342–343.
9. Padhye, S., Ahmad, A., Oswal, N., and Sarkar, F. H. (2009) J. Hematol. Oncol. 2, 1756–8722.
10. Chen, X., Zhang, X., Lu, Y., Shim, J. Y., Sang, S., and Sun, Z. (2012) Nutr. Cancer. 64, 1211–1218.
11. Hong, J., Sang, S., Park, H. J., Kwon, S. J., Suh, N., Huang, M. T., Ho, C. T., and Yang, C. S. (2006) Carcinogenesis 27, 278–286.
12. Tsai, M. L., Chiou, Y. S., Chiou, L. Y., Ho, C. T., and Pan, M. H. (2014) Mol. Nutr. Food Res. 58, 1820–1829.
13. Abulwerdi, F., Liao, C., Liu, M., Azmi, A. S., Aboukameel, A., Mady, A. S., Gulappa, T., Cierpicki, T., Owens, S., Zhang, T., Sun, D., Stuckey, J. A., Mohammad, R. M., and Nikolovska-Coleska, Z. (2014) Mol. Cancer Ther. 13, 565–575.
14. Bao, B., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., Aboukameel, A., Mohammad, R., Van Buren, E., Azmi, A. S., and Sarkar, F. H. (2014) Stem Cells Dev. 23, 1947–1958.
15. Batchu, R. B., Qazi, A. M., Gruzdyn, O. V., Semaan, A., Seward, S. M., Chamala, S., Dhulipala, V. B., Bouwman, D. L., Weaver, D. W., and Gruber, S. A. (2013) Surgery 154, 739–746; discussion 746–737.
16. Li, S. H., Fu, J., Watkins, D. N., Srivastava, R. K., and Shankar, S. (2013) Mol. Cell. Biochem. 373, 217–227.
17. Xin, Y., Shen, X. D., Cheng, L., Hong, D. F., and Chen, B. (2014) Cancer Chemother. Pharmacol. 73, 711–719.
18. Hu, Y., Su, H., Li, X., Guo, G., Cheng, L., Qin, R., Qing, G., and Liu, H. (2015) Mol. Cancer Ther. 14, 289–297.
19. Thomas, M. M., Zhang, Y., Mathew, E., Kane, K. T., Maillard, I., and Pasca di Magliano, M. (2014) BMC Cancer 14, 862.
20. Avasarala, S., Van Scoyk, M., Wang, J., Sechler, M., Vandervest, K., Brzezinski, C., Weekes, C., Edwards, M. G., Arcaroli, J., Davis, R. E., Bikkavilli, R. K., and Winn, R. A. (2013) Biol. Open 2, 675–685.
21. Yang, C. N., Deng, Y. T., Tang, J. Y., Cheng, S. J., Chen, S. T., Li, Y. J., Wu, T. S., Yang, M. H., Lin, B. R., Kuo, M. Y., Ko, J. Y., and Chang, C. C. (2015) Oral Oncol. 51, 170–177.
22. Bu, Q., Fang, Y., Cao, Y., Chen, Q., and Liu, Y. (2014) Mol. Med. Rep. 10, 2203–2209.
23. Gibert, B., Delloye-Bourgeois, C., Gattolliat, C. H., Meurette, O., Le Guernevel, S., Fombonne, J., Ducarouge, B., Lavial, F., Bouhallier, F., Creveaux, M., Negulescu, A. M., Benard, J., Janoueix-Lerosey, I., Harel-Bellan, A., Delattre, O., and Mehlen, P. (2014) J. Natl. Cancer Instit. 106.
24. Sui, H., Cai, G. X., Pan, S. F., Deng, W. L., Wang, Y. W., Chen, Z. S., Cai, S. J., Zhu, H. R., and Li, Q. (2014) Mol. Cancer Ther. 13, 3137–3151.
25. Singh, S. K., Chen, N. M., Hessmann, E., Siveke, J., Lahmann, M., Singh, G., Voelker, N., Vogt, S., Esposito, I., Schmidt, A., Brendel, C., Stiewe, T., Gaedcke, J., Merenberger, M., Crawford, H. C., Bamlet, W. R., Zhang, J. S., Li, X. K., Smyrk, T. C., Billadeau, D. D., Hebrok, M., Neesse, A., Koenig, A., and Ellenrieder, V. (2015) EMBO J. 34, 517–530.
26. Xue, Z. X., Zheng, J. H., Zheng, Z. Q., Cai, J. L., Ye, X. H., Wang, C., Sun, W. J., Zhou, X., Lu, M. D., Li, P. H., and Cai, Z. Z. (2014) World J. Surg. Oncol. 12, 404.
27. Wang, Z., Ahmad, A., Li, Y., Azmi, A. S., Miele, L., and Sarkar, F. H. (2011) Anticancer Res. 31, 1105–1113.
28. Mathew, G., Timm, E. A., Jr., Sotomayor, P., Godoy, A., Montecinos, V. P., Smith, G. J., and Huss, W. J. (2009) Cell Cycle 8, 1053–1061.
29. Chen, Z. S., Ling, D. J., Zhang, Y. D., Feng, J. X., Zhang, X. Y., and Shi, T. S. (2015) Mol. Med. Rep. 11, 1851–1858.
30. Dotse, E., and Bian, Y. (2014) Cytotechnology 23, 23.
31. Li, P., Ma, X., Adams, I. R., and Yuan, P. (2015) Cell Death Dis. 8, 551.
32. Zuo, J., Guo, Y., Peng, X., Tang, Y., Zhang, X., He, P., Li, S., Wa, Q., Li, J., Huang, S., and Xu, D. (2015) Oncol. Rep. 33, 1388–1394.
33. Shinmura, K., Kato, H., Igarashi, H., Inoue, Y., Nakamura, S., Du, C., Kurachi, K., Nakamura, T., Ogawa, H., Tanahashi, M., Niwa, H., and Sugimura, H. (2015) Pathol. Oncol. Res. 10, 759–764.
34. Wu, X. J., Li, X. D., Zhang, H., Zhang, X., Ning, Z. H., Yin, Y. M., and Tian, Y. (2015) J. Int. Med. Res. 43, 173–179.
35. Ye, X., Yuan, L., Zhang, L., Zhao, J., Zhang, C. M., and Deng, H. Y. (2014) Asian Pac. J. Cancer Prev. 15, 5001–5007.
36. Samulitis, B. K., Pond, K., Pond, E., Cress, A. E., Patel, H., Wisner, L., Patel, C., Dorr, R. T., and Landowski, T. H. (2014) Cancer Biol. Ther. 16, 43–51.
37. Parasramka, M. A., and Gupta, S. V. (2011) Nutr. Cancer 63, 456–465.
38. Maftouh, M., Avan, A., Funel, N., Paolicchi, E., Vasile, E., Pacetti, P., Vaccaro, V., Faviana, P., Campani, D., Caponi, S., Mambrini, A., Boggi, U., Cantore, M., Milella, M., Peters, G. J., Reni, M., and Giovannetti, E. (2014) Pharmacogenomics 15, 609–618.
39. Batliner, J., Buehrer, E., Federzoni, E. A., Jenal, M., Tobler, A., Torbett, B. E., Fey, M. F., and Tschan, M. P. (2012) Br. J. Haematol. 157, 270–274.
40. Wang, X., Gocek, E., Liu, C. G., and Studzinski, G. P. (2009) Cell Cycle 8, 736–741.
41. Zimmerman, E. I., Dollins, C. M., Crawford, M., Grant, S., Nana-Sinkam, S. P., Richards, K. L., Hammond, S. M., and Graves, L. M. (2010) Mol. Pharmacol. 78, 811–817.